A New Immunological Treatment of Prostate Cancer Using an Apoptotic Enhancement Therapy Drug, Alisertib

Image
Zoom inZoom inZoom inZoom in
Zoom outZoom outZoom outZoom out
Go homeGo homeGo homeGo home
Toggle full pageToggle full pageToggle full pageToggle full page
Glass, S., Showalter, L., & Koski, G. (2017). A New Immunological Treatment of Prostate Cancer Using an Apoptotic Enhancement Therapy Drug, Alisertib (1–). https://oaks.kent.edu/node/5459
Glass, Sierra, Lori Showalter, and Gary Koski. 2017. “A New Immunological Treatment of Prostate Cancer Using an Apoptotic Enhancement Therapy Drug, Alisertib”. https://oaks.kent.edu/node/5459.
Glass, Sierra, et al. A New Immunological Treatment of Prostate Cancer Using an Apoptotic Enhancement Therapy Drug, Alisertib. 21 Mar. 2017, https://oaks.kent.edu/node/5459.